SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-20-000088
Filing Date
2020-05-28
Accepted
2020-05-28 17:07:23
Documents
14
Period of Report
2020-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K ebs-2020x05x28acampres.htm   iXBRL 8-K 42488
  Complete submission text file 0001367644-20-000088.txt   190811

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20200528.xsd EX-101.SCH 4492
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebs-20200528_cal.xml EX-101.CAL 662
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20200528_def.xml EX-101.DEF 1512
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20200528_lab.xml EX-101.LAB 27268
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20200528_pre.xml EX-101.PRE 14152
15 EXTRACTED XBRL INSTANCE DOCUMENT ebs-2020x05x28acampres_htm.xml XML 4582
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 20922180
SIC: 2834 Pharmaceutical Preparations